Alexandra Boer Kimball MD MPH

Summary

• Dr. Kimball is CEO and President of Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center, an academic multi-specialty 501(c)3 physician organization with over 2400 employees, over 1 billion in revenue, and recognized by the Boston Globe as a top 10 Woman Led Business in Massachusetts. The group employs physicians and providers who practice in the Boston area, two-thirds of whom are Harvard Medical School faculty. She co-chairs the Beth Israel Lahey Health Performance Network Board (1.3 million members) and is on the Board of Trustees of Beth Israel Lahey Health. A Professor of Dermatology at Harvard Medical School, Dr. Kimball’s research focus is psoriasis and hidradenitis suppurativa. She has published over 395 papers (https://www.ncbi.nlm.nih.gov/myncbi/alexa.kimball.1/bibliography/public/), conducted over 150 clinical trials and has extensive experience in drug development and innovation, including two patents and licensing agreements. Awards include Modern Health Care's 50 Most Influential Clinical Executives, the American Skin Association Research Award for Health Policy and Medical Education, Mentor of the Year from the Women's Dermatologic Society, the Lifetime Achievement Award from the National Psoriasis Foundation, and the Joseph B. Martin Dean's Leadership Award for the Advancement of Women Faculty at Harvard Medical School. Dr. Kimball also served on the Advisory Council to the Director of the National Institutes of Health. She received her MD from the Yale School of Medicine, her MPH from the Johns Hopkins Bloomberg School of Public Health, and a bachelor's degree in molecular biology and public and international affairs from Princeton University. She completed an internship in medicine at Boston's Beth Israel Hospital, her residency in dermatology at Stanford University Medical Center and a clinical research fellowship at the National Institutes of Health.